206 related articles for article (PubMed ID: 23825673)
1. Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors.
Hubertus J; Zitzmann F; Trippel F; Müller-Höcker J; Stehr M; von Schweinitz D; Kappler R
PLoS One; 2013; 8(6):e67605. PubMed ID: 23825673
[TBL] [Abstract][Full Text] [Related]
2. The putative Neuronatin imprint control region is an enhancer that also regulates the Blcap gene.
Thamban T; Sowpati DT; Pai V; Nithianandam V; Abe T; Shioi G; Mishra RK; Khosla S
Epigenomics; 2019 Feb; 11(3):251-266. PubMed ID: 30672333
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of imprinted genes in Wilms tumors.
Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
[TBL] [Abstract][Full Text] [Related]
4. Transcript- and tissue-specific imprinting of a tumour suppressor gene.
Schulz R; McCole RB; Woodfine K; Wood AJ; Chahal M; Monk D; Moore GE; Oakey RJ
Hum Mol Genet; 2009 Jan; 18(1):118-27. PubMed ID: 18836209
[TBL] [Abstract][Full Text] [Related]
5. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.
Braunschweig MH; Owczarek-Lipska M; Stahlberger-Saitbekova N
BMC Genet; 2011 May; 12():47. PubMed ID: 21575277
[TBL] [Abstract][Full Text] [Related]
6. The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2.
Evans HK; Wylie AA; Murphy SK; Jirtle RL
Genomics; 2001 Sep; 77(1-2):99-104. PubMed ID: 11543638
[TBL] [Abstract][Full Text] [Related]
7. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19.
Takada S; Paulsen M; Tevendale M; Tsai CE; Kelsey G; Cattanach BM; Ferguson-Smith AC
Hum Mol Genet; 2002 Jan; 11(1):77-86. PubMed ID: 11773001
[TBL] [Abstract][Full Text] [Related]
13. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.
Bell AC; Felsenfeld G
Nature; 2000 May; 405(6785):482-5. PubMed ID: 10839546
[TBL] [Abstract][Full Text] [Related]
14. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
[TBL] [Abstract][Full Text] [Related]
16. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
[TBL] [Abstract][Full Text] [Related]
17. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region.
Tost J; Jammes H; Dupont JM; Buffat C; Robert B; Mignot TM; Mondon F; Carbonne B; Siméoni U; Grangé G; Kerjean A; Ferré F; Gut IG; Vaiman D
Nucleic Acids Res; 2006; 34(19):5438-48. PubMed ID: 17012269
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
[TBL] [Abstract][Full Text] [Related]
19. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation at the Igf2/H19 imprinting control region is associated with cerebellum mass in outbred mice.
Pidsley R; Fernandes C; Viana J; Paya-Cano JL; Liu L; Smith RG; Schalkwyk LC; Mill J
Mol Brain; 2012 Dec; 5():42. PubMed ID: 23216893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
